These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 17697196)
21. TACI deficiency - a complex system out of balance. Salzer U; Grimbacher B Curr Opin Immunol; 2021 Aug; 71():81-88. PubMed ID: 34247095 [TBL] [Abstract][Full Text] [Related]
22. CVID-associated TACI mutations affect autoreactive B cell selection and activation. Romberg N; Chamberlain N; Saadoun D; Gentile M; Kinnunen T; Ng YS; Virdee M; Menard L; Cantaert T; Morbach H; Rachid R; Martinez-Pomar N; Matamoros N; Geha R; Grimbacher B; Cerutti A; Cunningham-Rundles C; Meffre E J Clin Invest; 2013 Oct; 123(10):4283-93. PubMed ID: 24051380 [TBL] [Abstract][Full Text] [Related]
23. Common variable immunodeficiency: two mutations are better than one. La Cava A J Clin Invest; 2013 Oct; 123(10):4142-3. PubMed ID: 24051372 [TBL] [Abstract][Full Text] [Related]
24. "A rose is a rose is a rose," but CVID is Not CVID common variable immune deficiency (CVID), what do we know in 2011? Yong PF; Thaventhiran JE; Grimbacher B Adv Immunol; 2011; 111():47-107. PubMed ID: 21970952 [TBL] [Abstract][Full Text] [Related]
25. TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development. Romberg N; Virdee M; Chamberlain N; Oe T; Schickel JN; Perkins T; Cantaert T; Rachid R; Rosengren S; Palazzo R; Geha R; Cunningham-Rundles C; Meffre E J Allergy Clin Immunol; 2015 Nov; 136(5):1315-25. PubMed ID: 26100089 [TBL] [Abstract][Full Text] [Related]
26. Clinical variability of family members with the C104R mutation in transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI). Koopmans W; Woon ST; Brooks AE; Dunbar PR; Browett P; Ameratunga R J Clin Immunol; 2013 Jan; 33(1):68-73. PubMed ID: 22983507 [TBL] [Abstract][Full Text] [Related]
27. Analysis of TACI mutations in CVID & RESPI patients who have inherited HLA B*44 or HLA*B8. Waldrep ML; Zhuang Y; Schroeder HW BMC Med Genet; 2009 Sep; 10():100. PubMed ID: 19775471 [TBL] [Abstract][Full Text] [Related]
28. High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency. Knight AK; Radigan L; Marron T; Langs A; Zhang L; Cunningham-Rundles C Clin Immunol; 2007 Aug; 124(2):182-9. PubMed ID: 17556024 [TBL] [Abstract][Full Text] [Related]
29. Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID). Garibyan L; Lobito AA; Siegel RM; Call ME; Wucherpfennig KW; Geha RS J Clin Invest; 2007 Jun; 117(6):1550-7. PubMed ID: 17492055 [TBL] [Abstract][Full Text] [Related]
30. Phenotypic and clinical heterogeneity associated with monoallelic TNFRSF13B-A181E mutations in common variable immunodeficiency. Dong X; Hoeltzle MV; Hagan JB; Park MA; Li JT; Abraham RS Hum Immunol; 2010 May; 71(5):505-11. PubMed ID: 20156508 [TBL] [Abstract][Full Text] [Related]
31. Common variable immunodeficiency. Old questions are getting clearer. Blanco-Quirós A; Solís-Sánchez P; Garrote-Adrados JA; Arranz-Sanz E Allergol Immunopathol (Madr); 2006; 34(6):263-75. PubMed ID: 17173844 [TBL] [Abstract][Full Text] [Related]
32. Primary B cell immunodeficiencies: comparisons and contrasts. Conley ME; Dobbs AK; Farmer DM; Kilic S; Paris K; Grigoriadou S; Coustan-Smith E; Howard V; Campana D Annu Rev Immunol; 2009; 27():199-227. PubMed ID: 19302039 [TBL] [Abstract][Full Text] [Related]
33. TNFRSF13B/TACI alterations in Greek patients with antibody deficiencies. Speletas M; Mamara A; Papadopoulou-Alataki E; Iordanakis G; Liadaki K; Bardaka F; Kanariou M; Germenis AE J Clin Immunol; 2011 Aug; 31(4):550-9. PubMed ID: 21547394 [TBL] [Abstract][Full Text] [Related]
34. Evaluating the Genetics of Common Variable Immunodeficiency: Monogenetic Model and Beyond. de Valles-Ibáñez G; Esteve-Solé A; Piquer M; González-Navarro EA; Hernandez-Rodriguez J; Laayouni H; González-Roca E; Plaza-Martin AM; Deyà-Martínez Á; Martín-Nalda A; Martínez-Gallo M; García-Prat M; Del Pino-Molina L; Cuscó I; Codina-Solà M; Batlle-Masó L; Solís-Moruno M; Marquès-Bonet T; Bosch E; López-Granados E; Aróstegui JI; Soler-Palacín P; Colobran R; Yagüe J; Alsina L; Juan M; Casals F Front Immunol; 2018; 9():636. PubMed ID: 29867916 [TBL] [Abstract][Full Text] [Related]
35. The role of costimulation in antibody deficiencies: ICOS and common variable immunodeficiency. Yong PF; Salzer U; Grimbacher B Immunol Rev; 2009 May; 229(1):101-13. PubMed ID: 19426217 [TBL] [Abstract][Full Text] [Related]
37. Immunological characteristics and two novel mutations in TACI in a cohort of 28 pediatric patients with common variable immunodeficiency. Almejún MB; Sajaroff E; Galicchio M; Oleastro M; Bernasconi A; Zelazko M; Danielian S J Clin Immunol; 2012 Feb; 32(1):89-97. PubMed ID: 22076597 [TBL] [Abstract][Full Text] [Related]
38. TACI is mutant in common variable immunodeficiency and IgA deficiency. Castigli E; Wilson SA; Garibyan L; Rachid R; Bonilla F; Schneider L; Geha RS Nat Genet; 2005 Aug; 37(8):829-34. PubMed ID: 16007086 [TBL] [Abstract][Full Text] [Related]
39. Genetic defects in common variable immunodeficiency. Kopecký O; Lukesová S Int J Immunogenet; 2007 Aug; 34(4):225-9. PubMed ID: 17627754 [TBL] [Abstract][Full Text] [Related]
40. Genetic defects and the role of helper T-cells in the pathogenesis of common variable immunodeficiency. Yazdani R; Hakemi MG; Sherkat R; Homayouni V; Farahani R Adv Biomed Res; 2014; 3():2. PubMed ID: 24600593 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]